Article 04 Feb 2025 New PMPRB Draft Guidelines Outline Administrative Process For Excessive Price Hearing Recommendations Canada Healthcare
Article 01 Nov 2024 Evolving Pharmacy Landscape Signals More Stringent Regulatory Scrutiny Of "Patient Steering" Canada Healthcare
Article 02 Sep 2024 Boehringer Ingelheim Succeeds In Nintedanib PMNOC Action Against JAMP Canada Healthcare
Article 31 Jul 2024 Discussion Guide For PMPRB Phase 2 Consultations On New Guidelines Outlines Proposed New Framework For Patented Medicine Price Review Canada Healthcare
Article 02 Apr 2024 Generic Submissions Under Review List Will Identify Generic Filers Canada Healthcare
Article 03 Mar 2023 Federal Court Dismisses Takeda's Motion To Consolidate Two Dexlansoprazole PMNOC Actions Against Apotex Canada IP
Article 26 Jan 2023 Federal Court Of Appeal Restores Minister Of Health's Decision To Grant RUZURGI NOC Despite FIRDAPSE Data Protection Canada Healthcare
Article 22 Nov 2022 Federal Court Of Appeal Upholds Obviousness Finding Re: Janssen's Abiraterone Acetate And Prednisone Combination Therapy Patent Canada IP
Article 27 Sep 2022 Sandoz Granted Leave To Add New Allegations On Condition Of Trial Adjournment And Extension Of 24-month Stay Canada Healthcare